The estimated Net Worth of Lucas W. Buchanan is at least 25.7 百万$ dollars as of 1 March 2024. Mr. Buchanan owns over 9,877 units of Silk Road Medical Inc stock worth over 13,645,197$ and over the last 6 years he sold SILK stock worth over 10,681,604$. In addition, he makes 1,376,200$ as Chief Financial Officer、 Chief Operating Officer at Silk Road Medical Inc.
Lucas has made over 41 trades of the Silk Road Medical Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 9,877 units of SILK stock worth 169,588$ on 1 March 2024.
The largest trade he's ever made was selling 86,244 units of Silk Road Medical Inc stock on 17 January 2023 worth over 4,663,213$. On average, Lucas trades about 11,746 units every 31 days since 2019. As of 1 March 2024 he still owns at least 500,925 units of Silk Road Medical Inc stock.
You can see the complete history of Mr. Buchanan stock trades at the bottom of the page.
Lucas W. Buchanan has been appointed as Chief Financial Officer, Chief Operating Officer of the Company effective 10/1/2020. He has served as the Company’s Chief Financial Officer since July 2016 and since August 2009 has held multiple roles including Executive Vice President, Commercialization and Corporate Development and Vice President, Marketing and Business Development. From May 2013 to May 2014, Mr. Buchanan was a Senior Director of Strategy and Corporate Development at Impax Laboratories. From 2009 to 2011, Mr. Buchanan was part of the Company’s early team while employed at The Vertical Group, a venture capital firm and the founder of the Company. He previously worked at Medtronic and at Ernst & Young Corporate Finance LLC. Mr. Buchanan received a B.A. in economics from Duke University and an M.B.A. in health care management from The Wharton School at the University of Pennsylvania.
As the Chief Financial Officer、 Chief Operating Officer of Silk Road Medical Inc, the total compensation of Lucas Buchanan at Silk Road Medical Inc is 1,376,200$. There are 1 executives at Silk Road Medical Inc getting paid more, with Erica Rogers having the highest compensation of 3,679,060$.
Lucas Buchanan is 43, he's been the Chief Financial Officer、 Chief Operating Officer of Silk Road Medical Inc since 2020. There are 12 older and 1 younger executives at Silk Road Medical Inc. The oldest executive at Silk Road Medical Inc is Jack Lasersohn, 66, who is the Independent Director.
Lucas's mailing address filed with the SEC is C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE, CA, 94089.
Over the last 6 years, insiders at Silk Road Medical Inc have traded over 925,682,871$ worth of Silk Road Medical Inc stock and bought 14,200 units worth 302,033$ . The most active insiders traders include X Finance, L.P.Wpx Gp, L.P....、Pincus & Co.Kaye Charles R ...、Pincus & Co.Warburg Pincus .... On average, Silk Road Medical Inc executives and independent directors trade stock every 12 days with the average trade being worth of 4,280,712$. The most recent stock trade was executed by Kevin M Klemz on 19 August 2024, trading 2,268 units of SILK stock currently worth 61,463$.
silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th
Silk Road Medical Inc executives and other stock owners filed with the SEC include: